empower compounded tirzepatide Ivím Health BPI Labs joins Empower Pharmacy

In terms of tolerability, tirzepatide generally causes fewer gastrointestinal side effects, making it a better option for those sensitive to nausea, while Semaglutide GLP-1 may cause mild to moderate gastrointestinal issues like nausea and diarrhea, which usually subside over time

With regular application, it minimizes the appearance of fine lines and helps maintain elasticity

Tirzepatide (sold as Mounjaro for Type 2 diabetes and Zepbound for weight loss) has garnered attention for its dual-action ability to lower blood sugar and support weight loss

The dose may be increased in 2.5 mg increments every four weeks as needed, based on your progress and tolerance